Loading Please Wait
Call Toll Free:
877-985-2695
Sign in
|
Join
|
Help
SEARCH:
Home
Products
Articles
Health Blog
Pets
Fitness
Videos
My Clinic
Contact Us
The World's #1 Natural Health Website
†
Loading Please Wait
INVITE YOUR FRIENDS
Import Email Addresses from almost any email service to invite your friends.
Article Tools
Print this Page
Save as Favorites
My Saved Articles
Current Newsletter
Share Your Comment
Podcasts
Submit My Story
Newsletter Feed
Health Blog Feed
BROWSE BY
TAGS
Aging
Allergies
Alzheimers
Arthritis
Aspartame
Asthma
Autism
Back Pain
Brain Health
Cancer
Children's Health
Cholesterol
Cold and Flu
Depression
Detoxification
Diabetes
Digestive Diseases
Digestive Health
Drug Industry
Drugs
EMF
Emotional Health
Entertainment
Fatigue
Fibromyalgia
Finances
Fitness/Exercise
Fluoride
Food
Fructose/Sugar
Gardening
GMO
Heart Disease
Heart Health
High Blood Pressure
Hormones
Immune Support
Joint Support
Juicing
Kids Video
Men's Health
Mercury Free Dentistry
Nutritional Typing
Obesity
Osteoporosis
Pet Videos
Pets
Politics
Raw Milk
Sexual Health
Sleep
Soy
Statins
Supplements
Technology
Thyroid Disease
Vaccines
Vision Health
Vitamin D
Water
Weight Management
Women's Health
TRANSLATE THIS PAGE:
Invite Your Friends
Invite Your Friends
FDA Continues to Support Drug Cartel
Posted By
Dr. Mercola
|
June 12 2007 |
3,436
views
Tweet
Email
Previous
Next
Email this article to a friend
What's more important when it comes to the
approval of new drugs
--safety or speed?
With drug companies paying millions of dollars in
"fees" to the FDA
to ensure speedy approvals for their drugs, the FDA's answer is ... speed.
Recent drug safety scandals have rocked the nation and brought the FDA in for questioning on Capitol Hill, with many questioning the FDA's ability to strike a good balance.
The tip-off, according to critics, is the increasing number of FDA drug-safety officers who are finally admitting to coersion, threats and retaliation from management, when bringing
safety issues
into the light.
The latest of these victims is Dr. Rosemary Johann-Liang, who quit her seven-year career with the
FDA
after being stripped of her independent judgment and excluded from crucial safety reviews and meetings by her boss Dr. Mark Avigan.
What was her undoing? Recommending boxed warning labels on the drugs
Avandia
and Actos, after determining these drugs induce swelling problems that can lead to visual problems, weight gain and ankle swelling that, if left untreated, may cause heart failure.
Everyone needs to be aware that taking
patent drugs
involves magnificent risks to their health, and that the pushing for quicker approvals in the name of "saving lives" is nothing but a pipe-dream, fueled by massive profits.
The New York Times June 11, 2007
Tweet
Email
Previous Article
Next Article
Loading Please Wait
View Comments (15)
POST YOUR COMMENT
Reply to this thread
(2000 Characters only.)
Characters remaining:
* Please enter your comment!
Edit Your Comment
(2000 Characters only.)
Characters remaining:
* Please enter your comment!
Comment deleted violating the aspect of our terms of use
Tweet
Email
Previous Article
Next Article
Please
or
to continue
.
Save Options
Private Favorites
(This will appear on your saved articles for later viewing)
Shared Favorites
(This will appear on your profile as one of your favorites)
Invite Your Friends
Invite Your Friends